Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association.

Breast

Axe Oncologie, Centre de Recherche du CHU de Québec - Université Laval, Québec, QC, Canada; Département de Médecine Sociale et Préventive, Faculté de médecine, Université Laval, Québec, QC, Canada; Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Québec, QC, Canada.

Published: June 2018

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.breast.2018.02.030	DOI Listing

Publication Analysis

Top Keywords

body mass

mass clinical

clinical outcomes

outcomes trastuzumab-treated

trastuzumab-treated metastatic

metastatic breast

breast cancer

cancer patients

patients alternative

alternative explanation

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!